|
CA2018248A1
(en)
|
1989-06-07 |
1990-12-07 |
Clyde W. Shearman |
Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
|
|
US6800738B1
(en)
|
1991-06-14 |
2004-10-05 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
|
JP4213224B2
(ja)
|
1997-05-02 |
2009-01-21 |
ジェネンテック，インコーポレーテッド |
ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
CA2410551A1
(en)
|
2000-06-30 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) |
Heterodimeric fusion proteins
|
|
DK1438400T3
(da)
|
2001-10-01 |
2009-10-05 |
Dyax Corp |
Flerkædede eukaryote display-vektorer og anvendelser deraf
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
NZ561338A
(en)
|
2005-04-01 |
2010-04-30 |
Immunocore Ltd |
High affinity HIV T cell receptors
|
|
EP3479844B1
(en)
|
2005-04-15 |
2023-11-22 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
|
US9284375B2
(en)
*
|
2005-04-15 |
2016-03-15 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
AT503861B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von t-zell-rezeptoren
|
|
US20100105136A1
(en)
|
2006-10-09 |
2010-04-29 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
US20110045007A1
(en)
|
2007-05-31 |
2011-02-24 |
Genmab A/S |
Fusion or linked proteins with extended half life
|
|
CA2711806A1
(en)
|
2008-01-11 |
2009-07-16 |
Morphosys Ag |
Display vectors and methods and uses thereof
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
US8465743B2
(en)
|
2009-10-01 |
2013-06-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
CA2777053A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
|
US20130129723A1
(en)
|
2009-12-29 |
2013-05-23 |
Emergent Product Development Seattle, Llc |
Heterodimer Binding Proteins and Uses Thereof
|
|
CN102958942A
(zh)
|
2009-12-29 |
2013-03-06 |
新兴产品开发西雅图有限公司 |
异二聚体结合蛋白及其应用
|
|
WO2011085178A1
(en)
|
2010-01-11 |
2011-07-14 |
Trustees Of Dartmouth College |
Monomeric bi-specific fusion protein
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
RS67768B1
(sr)
|
2010-11-30 |
2026-03-31 |
Chugai Pharmaceutical Co Ltd |
Terapijski agens koji indukuje citotoksičnost
|
|
SG193023A1
(en)
|
2011-02-11 |
2013-10-30 |
Sloan Kettering Inst Cancer |
Hla-restricted, peptide-specific antigen binding proteins
|
|
WO2013026837A1
(en)
*
|
2011-08-23 |
2013-02-28 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
UY34317A
(es)
|
2011-09-12 |
2013-02-28 |
Genzyme Corp |
Anticuerpo antireceptor de célula T (alfa)/ß
|
|
JP2015537043A
(ja)
|
2012-11-30 |
2015-12-24 |
ロシュ グリクアート アーゲー |
多機能タンパク質を含むがん細胞標的化ｍｈｃクラスｉを用いた循環性ウイルス特異的細胞傷害性ｔ細胞によるがん細胞の除去
|
|
MX375359B
(es)
|
2013-02-26 |
2025-03-06 |
Roche Glycart Ag |
Moléculas biespecíficas de unión a antígeno activadoras de células t.
|
|
CA2896359A1
(en)
|
2013-02-26 |
2014-09-04 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
JP6676521B2
(ja)
*
|
2013-03-14 |
2020-04-08 |
マクロジェニクス，インコーポレーテッド |
二重特異性分子、薬学的組成物及びそれらの使用
|
|
HRP20250551T1
(hr)
|
2013-11-27 |
2025-06-20 |
Zymeworks Bc Inc. |
Bispecifični antigen-vezujući konstrukti koji ciljaju her2
|
|
UA129760C2
(uk)
|
2013-12-17 |
2025-07-30 |
Дженентек, Інк. |
Анти-cd3 антитіло та спосіб його застосування
|
|
TR201907352T4
(tr)
|
2014-03-25 |
2019-06-21 |
Merial Inc |
Atenüe edi̇lmi̇ş histophilus somni i̇çeren i̇mmünoloji̇k bi̇leşi̇mler
|
|
MX2017001079A
(es)
|
2014-07-24 |
2017-09-12 |
Bluebird Bio Inc |
Receptores de antígeno quiméricos de antígeno de maduración de células b (bcma).
|
|
EP2985294A1
(en)
|
2014-08-14 |
2016-02-17 |
Deutsches Krebsforschungszentrum |
Recombinant antibody molecule and its use for target cell restricted T cell activation
|
|
CA2958200A1
(en)
|
2014-08-14 |
2016-02-18 |
Novartis Ag |
Treatment of cancer using a gfr alpha-4 chimeric antigen receptor
|
|
RS61010B1
(sr)
|
2014-11-20 |
2020-11-30 |
Hoffmann La Roche |
Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
US10744157B2
(en)
|
2015-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
CN107995913B
(zh)
|
2015-05-18 |
2022-02-11 |
T细胞受体治疗公司 |
使用融合蛋白对tcr重编程的组合物和方法
|
|
EP3095792A1
(en)
*
|
2015-05-19 |
2016-11-23 |
Klinikum rechts der Isar der Technischen Universität München |
T cell receptor with specificity for myeloperoxidase peptide and uses thereof
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
GB201512369D0
(en)
|
2015-07-15 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
US10130693B2
(en)
|
2015-08-28 |
2018-11-20 |
Immatics Biotechnologies Gmbh |
Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201515321D0
(en)
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
WO2017059900A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Cell & Gene Therapies Gmbh |
Antigen receptors and uses thereof
|
|
WO2017060201A1
(en)
|
2015-10-09 |
2017-04-13 |
Immatics Biotechnologies Gmbh |
Anti-wt1/hla-specific antibodies
|
|
EP3842450A1
(en)
*
|
2015-10-23 |
2021-06-30 |
Eureka Therapeutics, Inc. |
Antibody/t-cell receptor chimeric constructs and uses thereof
|
|
GB201521746D0
(en)
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
GB201522592D0
(en)
*
|
2015-12-22 |
2016-02-03 |
Immunocore Ltd |
T cell receptors
|
|
GB201602918D0
(en)
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
|
GB201603568D0
(en)
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
|
GB201603987D0
(en)
|
2016-03-08 |
2016-04-20 |
Immatics Biotechnologies Gmbh |
Uterine cancer treatments
|
|
US11034767B2
(en)
|
2016-04-15 |
2021-06-15 |
Trustees Of Dartmouth College |
High affinity B7-H6 antibodies and antibody fragments
|
|
EP3472208B9
(en)
|
2016-06-17 |
2023-10-04 |
Medigene Immunotherapies GmbH |
T cell receptors and uses thereof
|
|
EP3475938B1
(en)
|
2016-06-27 |
2020-12-23 |
The Procter and Gamble Company |
Apparatus and method for assessing tooth-sensitivity treatment by oral-care product
|
|
EP3494138A1
(en)
|
2016-08-02 |
2019-06-12 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018026018A1
(ja)
|
2016-08-05 |
2018-02-08 |
国立大学法人東北大学 |
Ｔ細胞受容体の認識機構を用いたがん又は感染症の治療及び診断
|
|
US11453726B2
(en)
|
2016-09-15 |
2022-09-27 |
Quadrucept Bio Limited |
Multimers, tetramers and octamers
|
|
CN106831996B
(zh)
*
|
2017-03-31 |
2020-05-19 |
北京智仁美博生物科技有限公司 |
具有cd3e和/或her2靶向功能的双特异性抗体及其用途
|
|
CN111094333A
(zh)
|
2017-06-01 |
2020-05-01 |
斯图加特大学 |
异源二聚化的Ig结构域
|
|
SG11202000025SA
(en)
|
2017-07-14 |
2020-02-27 |
Immatics Biotechnologies Gmbh |
Improved dual specificity polypeptide molecule
|
|
CN109468278A
(zh)
|
2017-09-08 |
2019-03-15 |
科济生物医药（上海）有限公司 |
基因工程化的t细胞及应用
|
|
JPWO2019151392A1
(ja)
|
2018-01-31 |
2021-02-04 |
国立大学法人東北大学 |
抗原特異的ｍｈｃ発現調節法
|
|
MX2020012124A
(es)
|
2018-05-14 |
2021-04-19 |
Immunocore Ltd |
Polipeptidos de unión bifuncional.
|
|
EA202091977A1
(ru)
|
2018-05-28 |
2021-02-09 |
Драгонфлай Терапьютикс, Инк. |
Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения
|
|
US20220275043A1
(en)
|
2018-07-17 |
2022-09-01 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
|
WO2020057610A1
(en)
|
2018-09-20 |
2020-03-26 |
Wuxi Biologics (Shanghai) Co., Ltd. |
Novel bispecific anti-ctla-4/pd-1 polypeptide complexes
|
|
GB201903767D0
(en)
|
2019-03-19 |
2019-05-01 |
Quadrucept Bio Ltd |
Multimers, tetramers & octamers
|
|
GB201906685D0
(en)
|
2019-05-13 |
2019-06-26 |
Ultrahuman Six Ltd |
Activatable protein constructs and uses thereof
|
|
MX2022000667A
(es)
|
2019-07-15 |
2022-07-21 |
Neogene Therapeutics B V |
Metodo para aislar genes tcr.
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
EP4025598A1
(en)
|
2019-09-06 |
2022-07-13 |
Eli Lilly and Company |
Proteins comprising t-cell receptor constant domains
|
|
US20220396635A1
(en)
|
2019-09-25 |
2022-12-15 |
Universität Stuttgart |
Trivalent binding molecules
|
|
EP4034570A4
(en)
|
2019-09-27 |
2023-10-25 |
Agenus Inc. |
HETERODIMERIC PROTEINS
|
|
AU2020384374A1
(en)
|
2019-11-15 |
2022-06-09 |
Seattle Project Corp. |
Antigen-binding proteins targeting shared neoantigens
|
|
EP4061827A1
(en)
|
2019-11-18 |
2022-09-28 |
BioNTech SE |
Prame tcr receptors and uses thereof
|
|
EP4077370A4
(en)
|
2019-12-17 |
2024-02-28 |
The Johns Hopkins University |
MANABODIES TARGETING TUMOR ANTIGENS AND METHODS OF USE
|
|
CN110964122B
(zh)
|
2019-12-24 |
2022-04-15 |
南京北恒生物科技有限公司 |
T细胞受体融合蛋白及其用途
|
|
JP2023518049A
(ja)
|
2020-03-16 |
2023-04-27 |
ユニバーシティ オブ サザン カリフォルニア |
新規な抗原結合ドメインおよびそれを組み込んだ合成抗原受容体
|
|
US20230130925A1
(en)
|
2020-03-16 |
2023-04-27 |
University Of Southern California |
Methods to prevent, ameliorate and treat complications from viral infections
|
|
WO2021222576A1
(en)
|
2020-05-01 |
2021-11-04 |
A2 Biotherapeutics, Inc. |
Pag1 fusion proteins and methods of making and using same
|
|
AU2021289612A1
(en)
|
2020-06-10 |
2023-01-19 |
The University Of Melbourne |
HIV-1 antibodies
|
|
EP4188416A4
(en)
|
2020-07-27 |
2024-08-21 |
Arizona Board of Regents on behalf of the University of Arizona |
MULTIFUNCTIONAL IMMUNOGLOBULIN-FOLDED POLYPEPTIDES FROM SUBSTITUTION TRANSLATIONAL INITIATION AND TERMINATION
|
|
US20230374140A1
(en)
|
2020-10-09 |
2023-11-23 |
Memorial Sloan Kettering Cancer Center |
Compositions targeting ndc80/mhc complexes and uses thereof
|
|
WO2022083668A1
(en)
|
2020-10-21 |
2022-04-28 |
Nanjing Legend Biotech Co., Ltd. |
Use of a chimeric co-stimulatory receptor for cell therapy
|
|
AU2021408160A1
(en)
|
2020-12-21 |
2023-06-29 |
Zymeworks Bc Inc. |
Stabilized tcr constructs and methods of use
|
|
AU2022224066A1
(en)
|
2021-02-19 |
2023-09-07 |
Angeles Therapeutics, Inc. |
Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
|